InteRNA Technologies
InteRNA Technologies is a privately held drug discovery and development company founded in 2006, with 11–50 employees, developing therapeutics and backed by specialist life sciences venture investors across multiple financing rounds totaling approximately $37.9M.
- Company typePrivate
- Founded2006
- HeadquartersNew Haven, United States
- Headcount11–50
- GTM typeB2C
- OfferingDigital Commerce or Content
What InteRNA Technologies does
InteRNA Technologies is a privately held drug discovery and development company founded in 2006, operating with a headcount of 11–50 employees. Its core activity is the development of therapeutics, with the leadership and capital structure indicating a focus on microRNA-based or related nucleotide therapeutics, consistent with the investor base of specialist life sciences VCs (Aglaia BioMedical Ventures, Inkef, Aurora Science, OostNL, Alumni Ventures) and regional Dutch public capital (Innovation & Investment Fund Gelderland).
The company has progressed through multiple private financing rounds between 2010 and 2021, with the largest disclosed raise of approximately $22.4M completed in February 2021 alongside a follow-on tranche in March 2021, bringing cumulative disclosed funding to roughly $37.9M. Governance is led by CEO Roel Schaapveld, with Hans GCP Schikan serving as Chairman of the supervisory board and two Chief Development Officers (Grégoire Prévost and Michel Janicot) supporting the R&D organization. The structure is consistent with a clinical-stage or late-preclinical European biotech preparing for pipeline advancement.
The firm's go-to-market model in its current stage is capital-driven rather than revenue-driven: there are no disclosed licensing deals, partnerships, or product revenues in the data, and customer concentration in the conventional sense is not applicable at this development stage. Public-facing technical detail on the proprietary drug discovery platform, pipeline assets, or target indications is limited in the available material, which constrains deeper technical assessment.
InteRNA Technologies firmographics
Firmographics- Name
- InteRNA Technologies
- Legal name
- InteRNA Technologies
- Website
- https://interna-technologies.com
- Company type
- Private
- Founded year
- 2006
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- InteRNA Technologies is a privately held drug discovery and development company founded in 2006, with 11–50 employees, developing therapeutics and backed by specialist life sciences venture investors across multiple financing rounds totaling approximately $37.9M.
- Ownership category
- akta.pro rank
InteRNA Technologies industry classification
Industry- Product category
- Online Gambling and Gaming
- NAICS
- Gambling Industries (7132), Other Gambling Industries (713290)
- SIC
- Services-Miscellaneous Amusement & Recreation (7990)
- akta.pro primary industry
- iGaming Platform Providers (Turnkey/Casino & Sportsbook Platforms) (MPAEAKAA)
- akta.pro secondary industries
- Online Casino Platform Providers (PAM, Wallet, CMS, Back Office) (MPAEABAK), iCasino Compliance, KYC/AML & Responsible Gaming Services (MPAEABAN)
Keywords
Where InteRNA Technologies is headquartered
LocationHeadquarters
- HQ city
- New Haven
- HQ country
- United States
- HQ region
- North America
Markets served
InteRNA Technologies business model
Business model- GTM type
- B2C
- Offering type
- Digital Commerce or Content
- Cost components
- Marketing or Sales, Operations, Technology or R&D, Personnel, Infrastructure
Revenue model
- Gaming Transaction Fees (Take Rate): Platform generates revenue through transaction fees on player deposits and withdrawals. All deposit methods listed as 0% fee to players (bank transfer, SmartLink, Codepay, card recharge, MoMo, giftcode), with platform revenue derived from game margins and house edge on casino games, slot machines (nổ hũ), sports betting odds, and lottery products.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | New Member Welcome Bonus |
Distribution channels3 records
Marketing channels3 records
InteRNA Technologies product offering
Product offeringCore offering
The company operates an online gambling aggregation portal serving the Vietnamese market. Its core offering is the HD88 portal, which aggregates and promotes multiple real-money gambling sub-brands including Hdbet, Ho88, Co88, So79, Tipclub, Nohu Win, and Okvip Top, alongside the Sunwin gaming platform. The portfolio includes slot machines (Nổ Hũ), fish shooting (Bắn Cá), live casino, dice games (Tài Xỉu, Xóc Đĩa), card games, sports betting, and online lottery, accessible via web and dedicated Android/iOS mobile applications.
Product overview
InteRNA Technologies operates a multi-platform online gaming and gambling aggregation portal serving the Vietnamese market. The core offering centers on HD88 as the primary brand, which aggregates and promotes multiple gambling sub-platforms including Hdbet, Sunwin, Ho88, Co88, So79, Tipclub, Nohu Win, and Okvip Top. The platform offers a comprehensive portfolio of gambling categories including slot machines (Nổ Hũ) with jackpot prizes up to 50 billion VND, fish shooting games (Bắn Cá), live casino (Casino Trực Tuyến), online dice games (Tài Xỉu, Xóc Đĩa), card games (Game Bài) like Tiến Lên and Phỏm, sports betting through K Sports, S Sports, IM Sports and B Sports, and online lottery (Lô Đề). Sunwin provides dedicated mobile applications for Android and iOS, along with a multi-method payment system supporting bank transfers, e-wallets, and mobile cards. The various sub-brands operate as distinct gambling platforms under promotional aggregation, each with their own member benefits and promotional structures.
Differentiator
Problem solved
Functional benefit
Products and services
- HD88
- Hdbet (HDBET)
- Ho88
- Co88
- So79
- Tipclub
- Nohu Win (Nohuwin)
- Okvip Top
- Sunwin
Quantifiable outcome
- 2-5 minute withdrawal processing vs 30-60 minutes for competitors
- +4 more outcomes
Companies that use InteRNA Technologies
Customer profileSegments1 record
Ideal customer profiles1 record
InteRNA Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
InteRNA Technologies partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights3 records
InteRNA Technologies competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Global CRO providing preclinical drug-discovery, safety assessment, and manufacturing services to pharma and biotech. Directly comparable as a drug-discovery services platform but operating at vastly greater scale across the full development pipeline.
- WuXi AppTec: China-based CRO/CDMO offering end-to-end drug-discovery, preclinical, and manufacturing services globally. Comparable discovery-services offering, though operating at significantly larger scale and with broader geographic reach.
- Eurofins Scientific: Global bioanalytical and contract-testing group with significant drug-discovery and pharma-services operations. Comparable in services offering but operates across many adjacent verticals (food, environmental, clinical) at much larger scale.
Direct peers
- Evotec SE: German-headquartered drug-discovery and development services company offering integrated small-molecule and biologics discovery platforms to pharma partners. Closely comparable business model, target customer set, and European base.
- Pharmaron: China/UK-based CRO providing drug-discovery, preclinical, and clinical development services to biotech and pharma clients. Comparable fee-for-service drug-discovery model with similar customer profile.
- Sygnature Discovery: UK-based drug-discovery CRO specialising in medicinal chemistry, in vitro biology, and DMPK for pharma partners. Closely comparable size, scope, and customer type as a mid-sized European drug-discovery services firm.
- Crown Bioscience: Global CRO providing preclinical drug-discovery and translational oncology services to pharma and biotech clients. Comparable mid-sized CRO with overlapping discovery-services business.
Others
- Sartorius AG: German supplier of bioprocessing and lab technologies used in drug discovery and biomanufacturing. Adjacent rather than directly competitive, but a likely vendor/customer relationship for any biotech discovery services platform.
- Lonza Group: Swiss CDMO providing development and manufacturing services for biologics and small molecules. Adjacent rather than directly competitive, but a potential upstream/downstream partner for a discovery-stage biotech.
Emerging players
- Bio-Techne: Developer of life-science reagents, assays, and exosome-based platforms used in drug discovery and translational research. Partial overlap with the discovery-tools ecosystem and a comparable sub-scale peer in the broader biotech-tools category.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights5 records
Customer concentration
InteRNA Technologies social profiles
Digital presenceInteRNA Technologies compliance and trust
Trust signalCompliance4 records
InteRNA Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
InteRNA Technologies leadership team
Management profileNumber of profiles
InteRNA Technologies funding detail
Funding detailFunding overview
Funding rounds5 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InteRNA Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InteRNA Technologies
What does InteRNA Technologies do?
The company operates an online gambling aggregation portal serving the Vietnamese market. Its core offering is the HD88 portal, which aggregates and promotes multiple real-money gambling sub-brands including Hdbet, Ho88, Co88, So79, Tipclub, Nohu Win, and Okvip Top, alongside the Sunwin gaming platform. The portfolio includes slot machines (Nổ Hũ), fish shooting (Bắn Cá), live casino, dice games (Tài Xỉu, Xóc Đĩa), card games, sports betting, and online lottery, accessible via web and dedicated Android/iOS mobile applications.
Is InteRNA Technologies a public or private company?
InteRNA Technologies is a private company. It is classified as unknown and is currently operating.
When was InteRNA Technologies founded?
InteRNA Technologies was founded in 2006. It employs 11 to 50 people.
Where is InteRNA Technologies based?
InteRNA Technologies is headquartered in New Haven, United States, in the North America region.
How does InteRNA Technologies make money?
One revenue line is on record: gaming Transaction Fees (Take Rate).
Who are InteRNA Technologies's main competitors?
Broad incumbents on record are Charles River Laboratories, WuXi AppTec and Eurofins Scientific. Direct peers are Evotec SE, Pharmaron, Sygnature Discovery and Crown Bioscience. Others are Sartorius AG and Lonza Group. Bio-Techne is listed as an emerging player.
Does InteRNA Technologies have an API?
No public API is recorded for InteRNA Technologies.
What industry is InteRNA Technologies in?
InteRNA Technologies's product category is Online Gambling and Gaming. Its primary akta.pro industry code is MPAEAKAA, iGaming Platform Providers (Turnkey/Casino & Sportsbook Platforms), with a secondary code of MPAEABAK, Online Casino Platform Providers (PAM, Wallet, CMS, Back Office). Its NAICS code is 7132 and its SIC code is 7990.